Using electronic health records to drive discovery in disease genomics

Nature Reviews Genetics

Volumn 12, Issue 6, 2011, Pages 417-428

  Kohane, Isaac S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

COST EFFECTIVENESS ANALYSIS; ELECTRONIC MEDICAL RECORD; GENETIC VARIABILITY; GENOMICS; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; MEDICAL DOCUMENTATION; PATIENT CARE; POPULATION GENETICS; PRIORITY JOURNAL; PRIVACY; REVIEW;

ALLELES; DATA COLLECTION; ELECTRONIC HEALTH RECORDS; ETHNIC GROUPS; GENETIC DISEASES, INBORN; GENETIC VARIATION; GENETICS, MEDICAL; GENOME; GENOMICS; HUMANS; INFORMED CONSENT; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MODELS, GENETIC; PHENOTYPE; RESEARCH DESIGN;

EID: 79956327715     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2999     Document Type: Review

References (97)

1. Green, E. D., Guyer, M. S. & National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 470, 204-213 (2011).
2. Ioannidis, J. P., Trikalinos, T. A. & Khoury, M. J. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am. J. Epidemiol. 164, 609-614 (2006). (Pubitemid 44453487)
3. Dina, C. New insights into the genetics of body weight. Curr. Opin. Clin. Nutr. Metab. Care 11, 378-384 (2008).
4. Gauderman, W. J. Sample size requirements for association studies of gene-gene interaction. Am. J. Epidemiol. 155, 478-484 (2002). (Pubitemid 34174160)
5. Hein, R., Beckmann, L. & Chang-Claude, J. Sample size requirements for indirect association studies of gene-environment interactions (G x E). Genet. Epidemiol. 32, 235-245 (2008). (Pubitemid 351550370)
6. Manolio, T. A., Bailey-Wilson, J. E. & Collins, F. S. Genes, environment and the value of prospective cohort studies. Nature Rev. Genet. 7, 812-820 (2006). (Pubitemid 44413225)
7. Wheeler, D. A. et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452, 872-876 (2008). (Pubitemid 351550870)
8. Gismondi, P. M. et al. Strategies, time, and costs associated with the recruitment and enrollment of nursing home residents for a micronutrient supplementation clinical trial. J. Gerontol. A Biol. Sci. Med. Sci. 60, 1469-1474 (2005). (Pubitemid 41798457)
9. Noble, S. et al. Feasibility and cost of obtaining informed consent for essential review of medical records in large-scale health services research. J. Health Serv. Res. Policy 14, 77 (2009).
10. Schroy, P. C. et al. A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial. Clin. Trials 6, 597-609 (2009).
11. Zika, E. et al. A European survey on biobanks: trends and issues. Public Health Genomics 14, 96-103 (2010).
12. Tutton, R., Kaye, J. & Hoeyer, K. Governing UK Biobank: the importance of ensuring public trust. Trends Biotechnol. 22, 284-285 (2004). (Pubitemid 38639775)
13. Nakamura, Y. The BioBank Japan Project. Clin. Adv. Hematol. Oncol. 5, 696-697 (2007).
14. Hawkins, A. K. Biobanks: importance, implications and opportunities for genetic counselors. J. Genet. Couns. 19, 423-429 (2010).
15. Hewitt, R. E. Biobanking: the foundation of personalized medicine. Curr. Opin. Oncol. 23, 112-119 (2011).
16. Ballantyne, C. Report urges Europe to combine wealth of biobank data. Nature Med. 14, 701 (2008). (Pubitemid 351951504)
17. Founti, P. et al. Biobanks and the importance of detailed phenotyping: a case study - the European Glaucoma Society GlaucoGENE project. Br. J. Ophthalmol. 93, 577-581 (2009).
18. Tunis, S. R., Stryer, D. B. & Clancy, C. M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290, 1624-1632 (2003). (Pubitemid 37430387)
19. Charlson, M. E. & Horwitz, R. I. Applying results of randomised trials to clinical practice: impact of losses before randomisation. BMJ (Clin. Res. Ed.) 289, 1281-1284 (1984). (Pubitemid 15217616)
20. Pablos-Méndez, A., Barr, R. G. & Shea, S. Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 279, 222-225 (1998). (Pubitemid 28133785)
21. August, J. Market watch: emerging companion diagnostics for cancer drugs. Nature Rev. Drug Discov. 9, 351 (2010).
22. Brownstein, J. S., Freifeld, C. C., Reis, B. Y. & Mandl, K. D. Surveillance Sans Frontieres: Internet-based emerging infectious disease intelligence and the HealthMap project. PLoS Med. 5, e151 (2008).
23. Kielbasa, A. M., Pomerantz, A. M., Krohn, E. J. & Sullivan, B. F. How does clients' method of payment influence psychologists' diagnostic decisions? Ethics Behav. 14, 187-195 (2004). (Pubitemid 39604023)
24. Tuckson, R. V. et al. Policy issues associated with undertaking a new large, U. S. population cohort study of genes, environment, and disease. Department of Health and Human Services, Washington DC [online], http://oba.od.nih.gov/oba/sacghs/reports/SACGHS-LPS-report.pdf (2007).
25. Murphy, S. et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res. 19, 1675-1681 (2009).
26. Beasley, D. Remembering recruitment: the impact of proactive subject recruitment planning. Applied Clinical Trials Online [online], http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/ ClosingRecruitment/ArticleStandard/Article/detail/527739 (2008).
27. Jha, A. K. et al. Use of electronic health records in U. S. hospitals. N. Engl. J. Med. 360, 1628-1638 (2009).
28. Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S. & US National Human Genome Research Institute. A vision for the future of genomics research. Nature 422, 835-847 (2003). (Pubitemid 36520032)
29. Ranganathan, M. & Bhopal, R. Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies. PLoS Med. 3, e44 (2006).
30. Stone, V. E., Mauch, M. Y., Steger, K., Janas, S. F. & Craven, D. E. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J. Gen. Intern. Med. 12, 150-157 (1997). (Pubitemid 27180567)
31. Larson, E. Exclusion of certain groups from clinical research. Image J. Nurs. Sch. 26, 185-190 (1994).
32. Michelen, W., Martinez, J., Lee, A. & Wheeler, D. P. Reducing frequent flyer emergency department visits. J. Health Care Poor Underserved 17, 59-69 (2006). (Pubitemid 43340741)
33. Roby, D. H., Nicholson, G. L. & Kominski, G. F. African Americans in commercial HMOs more likely to delay prescription drugs and use the emergency room. UCLA Center for Health and Policy Research [online], http://www. healthpolicy.ucla.edu/pubs/Publication.aspx?pubID=371 (2009).
34. Jones, R., Lin, S., Munsie, J. P., Radigan, M. & Hwang, S. A. Racial/ethnic differences in asthma-related emergency department visits and hospitalizations among children with wheeze in Buffalo, New York. J. Asthma 45, 916-922 (2008).
35. Wolff, J. L., Starfield, B. & Anderson, G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch. Intern. Med. 162, 2269-2276 (2002). (Pubitemid 35332510)
36. Brownstein, J. S. et al. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care 33, 526-531 (2010).
37. Brownstein, J. S., Sordo, M., Kohane, I. S. & Mandl, K. D. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2, e840 (2007).
38. McCarty, C. A. & Wilke, R. A. Biobanking and pharmacogenomics. Pharmacogenomics 11, 637-641 (2010).
39. Kosoy, R. et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum. Mutat. 30, 69-78 (2009).
40. Dumitrescu, L. et al. Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records. Genet. Med. 12, 648-650 (2010).
41. Ioannidis, J. P. A. Non-replication and inconsistency in the genome-wide association setting. Hum. Hered. 64, 203-213 (2007). (Pubitemid 47036983)
42. Gulcher, J. & Stefansson, K. deCODE: A genealogical approach to human genetics in Iceland. Wiley Online Library [online], http://onlinelibrary.wiley. com/doi/10.1002/9780470015902.a0006270/abstract (2006).
43. Murphy, S. N., Mendis, M. E., Berkowicz, D. A., Kohane, I. S. & Chueh, H. C. Integration of clinical and genetic data in the i2b2 architecture. AMIA Annu. Symp. Proc., 1040 (2006).
44. Roden, D. M. et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin. Pharmacol. Ther. 84, 362-369 (2008).
45. Clayton, E. et al. Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet. Med. 12, 616-620 (2010).
46. Kullo, I. J., Ding, K., Jouni, H., Smith, C. Y. & Chute, C. G. A genome-wide association study of red blood cell traits using the electronic medical record. PLoS ONE 5, e13011 (2010).
47. Ritchie, M. et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am. J. Hum. Genet. 86, 560-572 (2010).
48. Kurreeman, F. et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am. J. Hum. Genet. 88, 57-69 (2011).
49. Melton, G. B. et al. Evaluation of family history information within clinical documents and adequacy of HL7 clinical statement and clinical genomics family history models for its representation: a case report. J. Am. Med. Inform. Assoc. 17, 337-340 (2010).
50. Sager, N., Lyman, M., Bucknall, C., Nhan, N. & Tick, L. J. Natural language processing and the representation of clinical data. J. Am. Med. Inform. Assoc. 1, 142-160 (1994).
51. Lindberg, D. A., Humphreys, B. L. & McCray, A. T. The unified medical language system. Methods Inf. Med. 32, 281-291 (1993). (Pubitemid 24244347)
52. Liao, K. P. et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res. (Hoboken) 62, 1120-1127 (2010).
53. Uzuner, O., Goldstein, I., Luo, Y. & Kohane, I. Identifying patient smoking status from medical discharge records. J. Am. Med. Inform. Assoc. 15, 14-24 (2008). (Pubitemid 350216492)
54. Jones, R., Pembrey, M., Golding, J. & Herrick, D. The search for genenotype/phenotype associations and the phenome scan. Paediatr. Perinat. Epidemiol. 19, 264-275 (2005). (Pubitemid 40897334)
55. Denny, J. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205-1210 (2010).
56. Loscalzo, J., Kohane, I. & Barabasi, A. L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol. Syst. Biol. 3, 124 (2007).
57. Murphy, S. N. et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J. Am. Med. Inform. Assoc. 17, 124-130 (2010).
58. Pulley, J., Clayton, E., Bernard, G., Roden, D. & Masys, D. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin. Transl. Sci. 3, 42-48 (2010).
59. Mailman, M. D. et al. The NCBI dbGaP database of genotypes and phenotypes. Nature Genet. 39, 1181-1186 (2007). (Pubitemid 47482671)
60. McGuire, A. L., Caulfield, T. & Cho, M. K. Research ethics and the challenge of whole-genome sequencing. Nature Rev. Genet. 9, 152-156 (2008). (Pubitemid 351147709)
61. Denny, J. et al. Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation 122, 2016-2021 (2010).
62. Hagen, S., Richmond, P., Vavrichek, B. & Baumgardner, J. Evidence on the costs and benefits of health information technology. Congressional Budget Office Washington DC [online], http://www.cbo.gov/ftpdocs/91xx/doc9168/ HealthITTOC.2.1.htm (2008).
63. DiLaura, R. P. Clinical and translational science sustainability: overcoming integration issues between electronic health records (EHR) and clinical research data management systems "separate but equal". Stud. Health Technol. Inform. 129, 137-141 (2007).
64. Scheuner, M. et al. Are electronic health records ready for genomic medicine? Genet. Med. 11, 510-517 (2009).
65. Sung, N. et al. Central challenges facing the national clinical research enterprise. JAMA 289, 1278-1287 (2003). (Pubitemid 37432909)
66. Uzuner, O., Solti, I. & Cadag, E. Extracting medication information from clinical text. J. Am. Med. Inform. Assoc. 17, 514-518 (2010).
67. Grannis, S. J., Overhage, J. M. & McDonald, C. J. Analysis of identifier performance using a deterministic linkage algorithm. Proc. AMIA Symp. 2002, 305-309 (2002).
68. Finney, J. M., Walker, A. S., Peto, T. E. & Wyllie, D. H. An efficient record linkage scheme using graphical analysis for identifier error detection. BMC Med. Inform. Decis. Mak. 11, 7 (2011).
69. Malin, B. A. An evaluation of the current state of genomic data privacy protection technology and a roadmap for the future. J. Am. Med. Inform. Assoc. 12, 28-34 (2005). (Pubitemid 40038620)
70. Barnes, D. Texas DNA Showdown. Mayborn, University of North Texas, Frank W. & Sue Mayborn School of Journalism [online], http://www.themayborn.com/ TexasDNAShowdown.html (2010).
71. Taylor, P. Personal genomes: when consent gets in the way. Nature 456, 32-33 (2008).
72. Kohane, I. S. et al. Medicine. Reestablishing the researcher-patient compact. Science 316, 836-837 (2007).
73. Kohane, I. S. & Taylor, P. L. Multidimensional results reporting to participants in genomic studies: getting it right. Sci. Transl. Med. 2, 37-19 (2010).
74. Van Der Lei, J. et al. The introduction of computer-based patient records in The Netherlands. Ann. Intern. Med. 119, 1036-1041 (1993).
75. Greenhalgh, T. et al. Adoption and non-adoption of a shared electronic summary record in England: a mixed-method case study. BMJ 340, c3111 (2010).
76. Jha, A. K., Doolan, D., Grandt, D., Scott, T. & Bates, D. W. The use of health information technology in seven nations. Int. J. Med. Inform. 77, 848-854 (2008).
77. De Lusignan, S., Metsemakers, J. F., Houwink, P., Gunnarsdottir, V. & Van Der Lei, J. Routinely collected general practice data: goldmines for research? A report of the European Federation for Medical Informatics Primary Care Informatics Working Group (EFMI PCIWG) from MIE2006, Maastricht, The Netherlands. Inform. Prim. Care 14, 203-209 (2006).
78. O'Brien, S. Stewardship of human biospecimens, DNA, genotype, and clinical data in the GWAS era. Annu. Reb. Genomics Hum. Genet. 10, 193-209 (2009).
79. Wolf, S. M. et al. Managing incidental findings in human subjects research: analysis and recommendations. J. Law Med. Ethics 36, 219-248 (2008).
80. Kohane, I. S., Masys, D. R. & Altman, R. B. The incidentalome: a threat to genomic medicine. JAMA 296, 212-215 (2006). (Pubitemid 44050375)
81. Thorisson, G. A., Muilu, J. & Brookes, A. J. Genotype-phenotype databases: challenges and solutions for the post-genomic era. Nature Rev. Genet. 10, 9-18 (2009).
82. Weber, G. M. et al. The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J. Am. Med. Inform. Assoc. 16, 624-630 (2009).
83. Haspel, R. L. et al. A call to action: training pathology residents in genomics and personalized medicine. Am. J. Clin. Pathol. 133, 832-834 (2010).
84. Freifeld, C. C. et al. Participatory epidemiology: use of mobile phones for community-based health reporting. PLoS Med. 7, e1000376 (2010).
85. Patel, C., Bhattacharya, J., Butte, A. J. & Zhang, B. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS ONE 5, e10746 (2010).
86. Pearson, J. F., Bachireddy, C., Shyamprasad, S., Goldfine, A. B. & Brownstein, J. S. Association between fine particulate matter and diabetes prevalence in the U. S. Diabetes Care 33, 2196-2201 (2010).
87. Pulley, J. M., Brace, M. M., Bernard, G. R. & Masys, D. R. Attitudes and perceptions of patients towards methods of establishing a DNA biobank. Cell Tissue Bank 9, 55-65 (2008). (Pubitemid 351279801)
88. Kohane, I. S. & Altman, R. B. Health-information altruists - a potentially critical resource. N. Engl. J. Med. 353, 2074-2077 (2005). (Pubitemid 41609103)
89. Murphy, J. et al. Public expectations for return of results from large-cohort genetic research. Am. J. Bioeth. 8, 36-43 (2008).
90. Kaufman, D., Murphy, J., Scott, J. & Hudson, K. Subjects matter: a survey of public opinions about a large genetic cohort study. Genet. Med. 10, 831-839 (2008).
91. Taylor, P. L. Rules of engagement. Nature 450, 163-164 (2007). (Pubitemid 350100517)
92. Taylor, P. L. Research sharing, ethics and public benefit. Nature Biotech. 25, 398-401 (2007). (Pubitemid 46572836)
93. Fung, K. W., McDonald, C. & Bray, B. E. RxTerms - a drug interface terminology derived from RxNorm. AMIA Annu. Symp. Proc. 2008, 227-231 (2008).
94. Harding, A. & Stuart-Buttle, C. The development and role of the Read Codes. J. AHIMA 69, 34-38 (1998). (Pubitemid 28213021)
95. International statistical classification of diseases and related health problems: 10th revision. World Health Organization [online], http://apps.who.int/classifications/apps/icd/icd10online (2007).
96. McCray, A. T. The Unified Medical Language System: The UMLS Semantic Network. Proc. Annu. Symp. Comput. Appl. Med. Care. 1989, 503-507 (1989).
97. Cote, R. A. & Robboy, S. Progress in medical information management: systematized nomenclature of medicine (SNOMED). JAMA 243, 756-762 (1980). (Pubitemid 10169321)